Introduction: Controversies in the Treatment of Hypertension J.I.S. RobertsonW.H. Birkenhäger OriginalPaper Pages: 355 - 355
Which Antihypertensive Drug Classes Have Been Shown to be Beneficial? What Are Their Benefits? A Critique of Hypertension Treatment Trials J.I.S. Robertson OriginalPaper Pages: 357 - 366
Should Dietary Salt Restriction Be a Basic Component of Antihypertensive Therapy? Niels GraudalAnders Galløe OriginalPaper Pages: 381 - 386
Genetic Mapping and Tailored Antihypertensive Therapy Patrizia FerrariGiuseppe Bianchi OriginalPaper Pages: 387 - 395
Is it Advantageous to Lower Cholesterol in the Elderly Hypertensive? Nigel BeckettMaria NunesChristopher Bulpitt OriginalPaper Pages: 397 - 405
Diuretic Downsides—But in Low Doses They Still Seem Among the Best Authenticated Antihypertensives Lionel H. Opie OriginalPaper Pages: 407 - 409
Efficacy of Two Lipid-Lowering Treatments on Quantitative Coronary Angiographic Endpoints W.J. MackM. XiangS.P. Azen OriginalPaper Pages: 411 - 418
Platelet Cyclic GMP Responses to Nitroglycerin Douglas D. MartinJeffrey S. TongJohn D. Parker OriginalPaper Pages: 419 - 425
Predicting Response to Chronic Antihypertensive Treatment with Fosinopril: The Role of Angiotensin-Converting Enzyme Gene Polymorphism George A. StavroulakisThomas K. MakrisMichael Kyriakidis OriginalPaper Pages: 427 - 432
β-adrenoceptor Modulation and Heart Rate Variability—The Value of Scatterplot Measures of Compactness B. SilkeC.G. HanrattyJ.G. Riddell OriginalPaper Pages: 433 - 440
Effect of Okadaic Acid, a Protein Phosphatase Inhibitor, on Heat Stress-Induced HSP72 Synthesis and Thermotolerance Marie JoyeuxClaire ArnaudChristophe Ribuot OriginalPaper Pages: 441 - 446
Tasosartan and Hydroclorothiazide as Combination Therapy in the Treatment of Severe Essential Hypertension: Comparison with Enalapril M. ViigimaaK. AllikmetsG. Häass OriginalPaper Pages: 447 - 449